Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I, Höffken K. Pachmann K, et al. Among authors: pachmann u. J Clin Oncol. 2008 Mar 10;26(8):1208-15. doi: 10.1200/JCO.2007.13.6523. J Clin Oncol. 2008. PMID: 18323545
Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment.
Camara O, Jörke C, Hammer U, Egbe A, Rabenstein C, Runnebaum IB, Hoeffken K, Pachmann K. Camara O, et al. Among authors: pachmann k. J Cancer Res Clin Oncol. 2009 Apr;135(4):643-7. doi: 10.1007/s00432-008-0498-8. Epub 2008 Oct 21. J Cancer Res Clin Oncol. 2009. PMID: 18936973
An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.
Pachmann K, Dengler R, Lobodasch K, Fröhlich F, Kroll T, Rengsberger M, Schubert R, Pachmann U. Pachmann K, et al. Among authors: pachmann u. J Cancer Res Clin Oncol. 2008 Jan;134(1):59-65. doi: 10.1007/s00432-007-0248-3. Epub 2007 Jul 5. J Cancer Res Clin Oncol. 2008. PMID: 17611779
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors.
Gajda M, Camara O, Oppel S, Kroll T, Jörke C, Krauspe S, Hammer U, Rabenstein C, Untch M, Runnebaum IB, Pachmann K. Gajda M, et al. Among authors: pachmann k. Ann Oncol. 2008 Dec;19(12):2090-1. doi: 10.1093/annonc/mdn648. Epub 2008 Sep 26. Ann Oncol. 2008. PMID: 18820243 Free PMC article. No abstract available.
94 results